The document announces a market research report from Global Markets Direct on SymBio Pharmaceuticals Limited's product pipeline. It provides an overview of SymBio's research areas and current developmental pipeline, including drug candidates in various stages of clinical trials for conditions like cancer. The report is based on proprietary data from Global Markets Direct as well as information from SymBio's corporate resources, and provides snapshots of individual drug candidates in development.